Literature DB >> 12809951

Dantrolene: effects on abnormal intracellular Ca(2+) handling and inotropy in postinfarcted rat myocardium.

Jiang-Yong Min1, Achim Meissner, Xin Feng, Jianan Wang, Sohail Malek, Ju-Feng Wang, Rudiger Simon, James P Morgan.   

Abstract

The present study was designed to investigate the effects of dantrolene on intracellular Ca(2+) ([Ca(2+)](i)) handling and inotropy in rat infarcted myocardium. Dantrolene-treated rats with myocardial infarction were placed into two different dosage groups. The infarcted control group received placebo only. Isometric contractility and intracellular Ca(2+) transients were recorded simultaneously in isolated papillary muscles. Diastolic [Ca(2+)](i) was significantly lower in muscle preparations from infarcted rats receiving dantrolene compared to the placebo control group. Additionally, treatment with dantrolene in infarcted rats significantly improved the inotropic response to 10(-4) M isoproterenol. The protein levels of the sarcoplasmic reticulum Ca(2+) ATPase were increased in infarcted rat hearts with dantrolene treatment. We conclude that dantrolene improved the inotropic response to beta-adrenoceptor stimulation in rat postinfarcted myocardium, which is related to improved intracellular Ca(2+) handling, and lowered diastolic Ca(2+) concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809951     DOI: 10.1016/s0014-2999(03)01816-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Probing a putative dantrolene-binding site on the cardiac ryanodine receptor.

Authors:  Kalanethee Paul-Pletzer; Takeshi Yamamoto; Noriaki Ikemoto; Leslie S Jimenez; Hiromi Morimoto; Philip G Williams; Jianjie Ma; Jerome Parness
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

2.  Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP.

Authors:  Paula L Diaz-Sylvester; Maura Porta; Julio A Copello
Journal:  Am J Physiol Cell Physiol       Date:  2008-02-27       Impact factor: 4.249

3.  Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.

Authors:  Shigeki Kobayashi; Masafumi Yano; Takeshi Suetomi; Makoto Ono; Hiroki Tateishi; Mamoru Mochizuki; Xiaojuan Xu; Hitoshi Uchinoumi; Shinichi Okuda; Takeshi Yamamoto; Noritaka Koseki; Hiroyuki Kyushiki; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

4.  Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice.

Authors:  James L Quinn; Tony Huynh; Kitipong Uaesoontrachoon; Kathleen Tatem; Aditi Phadke; Jack H Van der Meulen; Qing Yu; Kannaboyina Nagaraju
Journal:  PLoS Curr       Date:  2013-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.